Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2020-06-05 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
关于公司监事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company supervisor (监事) from the board of supervisors. It details the resignation, the legal implications, and the company's plan to fill the vacancy. There is no financial data, no mention of financial results, no audit information, no voting results, and no reference to any report publication. The content is about a change in the company's board-level personnel. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming the classification.
2020-06-05 Chinese
关于公司董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, Mr. Xu Wansheng, from the board of directors of Yunnan Watson Biotechnology Co., Ltd. It details the resignation effective date, the director's term, and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no voting results, or any other report type. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-06-05 Chinese
第四届董事会第十次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement from the board of directors of Yunnan Watson Biotechnology Co., Ltd. regarding the resolution of the 10th meeting of the 4th board of directors. It details the appointment of a senior management member, Mr. Zhang Jiankang, as the company's vice president. The document includes voting results and compliance statements but does not contain financial data or detailed financial performance. It is clearly a board/management information announcement about changes in senior management rather than a financial report or other filing type.
2020-05-29 Chinese
独立董事关于第四届董事会第十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding the appointment of a senior management member at Yunnan Watson Biotechnology Co., Ltd. It references compliance with laws, regulations, and company bylaws, and confirms the qualifications and suitability of the appointed individual. There is no financial data, no report publication, no voting results, no earnings or audit information, and no mention of a general meeting or shareholder vote. The content focuses on board/management information, specifically the appointment of a senior executive. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report but a substantive statement about management changes.
2020-05-29 Chinese
关于聘任公司高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management member (vice president) by the company's board of directors. It references compliance with stock exchange listing rules and company bylaws, and confirms the legality and appropriateness of the appointment. There is no financial data, no report attached or referenced as being published, and no mention of voting results or other report types. The content clearly fits the category of management information announcements about changes in senior management.
2020-05-29 Chinese
关于子公司完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Yunnan Watson Biotechnology Co., Ltd. regarding the completion of industrial and commercial registration changes for its subsidiary Shanghai Zerun Biotechnology Co., Ltd. It details changes in equity transfer and capital increase, including new investors and updated company registration information. The document is relatively short (1385 characters) and focuses on corporate structural changes rather than financial results or detailed reports. It does not contain financial statements or detailed financial analysis. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate changes and does not fit into more specific categories like Annual Report, Interim Report, or Capital/Financing Update which require substantive financial data or fundraising details. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-05-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.